DCM Shriram has announced a significant capital investment plan for its wholly-owned subsidiary, Hindusthan Specialty Chemicals Ltd (HSCL). The company will invest Rs 101 crores to augment HSCL’s Formulated Resins (FR) capacity by 36,000 tonnes per annum (TPA), bringing the total capacity to 50,000 TPA. This investment is part of DCM Shriram‘s strategy to strengthen its Advanced Materials portfolio within its Chemicals business.
The decision was made during a Board of Directors meeting held on 13th May 2026, where several other resolutions were also passed. The board approved the audited financial results for both standalone and consolidated operations for the quarter and financial year ending 31st March 2026. Additionally, the board recommended a final dividend of 200%, equating to ₹4 per equity share of ₹2 face value, subject to shareholder approval at the upcoming 37th Annual General Meeting (AGM). If approved, the total dividend for the financial year 2025-26 will amount to 560%, or ₹11.20 per equity share, including interim dividends declared earlier.
Furthermore, the board has scheduled the 37th AGM for 18th August 2026. It also approved the cancellation of 39,00,000 forfeited equity shares, initially forfeited in January 2005 due to non-payment of call money and later subdivided in October 2005.
The board meeting, which spanned two days, concluded on 13th May 2026. The outcomes of this meeting, including the financial results and investment plans, have been uploaded on the company’s official website.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).